Difficulty: Medium
Average Score: 71%
Practice
A patient has Stage III essential hypertension. After evaluating the responses to several other antihypertensive drugs, alone and in combination, the physician places the patient on oral hydralazine. Which of the following adjunct(s) is/are likely to be needed to manage the expected and unwanted cardiovascular side effects of the hydralazine?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Hydrochlorothiazide and a beta blocker. The rationale behind this choice lies in understanding the mechanism of action of hydralazine and its potential side effects. Hydralazine is a direct-acting vasodilator that can cause reflex tachycardia and sodium and water retention, leading to fluid overload and exacerbation of heart failure.
By adding Hydrochlorothiazide, a diuretic, the sodium and water retention caused by hydralazine can be counteracted, helping to prevent fluid overload and reduce blood pressure. Additionally, a beta blocker can help manage the reflex tachycardia induced by hydralazine, promoting a balanced cardiovascular response.
Now, looking at the other options:
A) Captopril plus nifedipine: While both are antihypertensive drugs, they do not directly address the specific side effects of hydralazine mentioned above.
B) Digoxin plus spironolactone: Digoxin is used in heart failure and spironolactone is a potassium-sparing diuretic, but they do not target the cardiovascular side effects of hydralazine.
C) Digoxin plus vitamin K: Digoxin is for heart conditions, and vitamin K is not relevant in managing the cardiovascular side effects of hydralazine.
Educationally, this question highlights the importance of understanding the mechanisms of action and potential side effects of cardiovascular drugs. It reinforces the concept of combination therapy in managing complex conditions like hypertension and underscores the need for a tailored approach to medication management based on individual patient responses and side effect profiles.
By adding Hydrochlorothiazide, a diuretic, the sodium and water retention caused by hydralazine can be counteracted, helping to prevent fluid overload and reduce blood pressure. Additionally, a beta blocker can help manage the reflex tachycardia induced by hydralazine, promoting a balanced cardiovascular response.
Now, looking at the other options:
A) Captopril plus nifedipine: While both are antihypertensive drugs, they do not directly address the specific side effects of hydralazine mentioned above.
B) Digoxin plus spironolactone: Digoxin is used in heart failure and spironolactone is a potassium-sparing diuretic, but they do not target the cardiovascular side effects of hydralazine.
C) Digoxin plus vitamin K: Digoxin is for heart conditions, and vitamin K is not relevant in managing the cardiovascular side effects of hydralazine.
Educationally, this question highlights the importance of understanding the mechanisms of action and potential side effects of cardiovascular drugs. It reinforces the concept of combination therapy in managing complex conditions like hypertension and underscores the need for a tailored approach to medication management based on individual patient responses and side effect profiles.